Randomized multicenter phase 2 study of pomalidomide, cyclophosphamide, and dexamethasone in relapsed refractory myeloma von Baz, Rachid C., Martin, Thomas G., Lin, Hui-Yi, Zhao, Xiuhua, Shain, Kenneth H., Cho, Hearn J., Wolf, Jeffrey L., Mahindra, Anuj, Chari, Ajai, Sullivan, Daniel M., Nardelli, Lisa A., Lau, Kenneth, Alsina, Melissa, Jagannath, Sundar

Volltext

The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance von Ferguson, Ian D., Patiño-Escobar, Bonell, Tuomivaara, Sami T., Lin, Yu-Hsiu T., Nix, Matthew A., Leung, Kevin K., Kasap, Corynn, Ramos, Emilio, Nieves Vasquez, Wilson, Talbot, Alexis, Hale, Martina, Naik, Akul, Kishishita, Audrey, Choudhry, Priya, Lopez-Girona, Antonia, Miao, Weili, Wong, Sandy W., Wolf, Jeffrey L., Martin, Thomas G., Shah, Nina, Vandenberg, Scott, Prakash, Sonam, Besse, Lenka, Driessen, Christoph, Posey, Avery D., Mullins, R. Dyche, Eyquem, Justin, Wells, James A., Wiita, Arun P.

Volltext

The p97 Inhibitor CB-5083 Is a Unique Disrupter of Protein Homeostasis in Models of Multiple Myeloma von Le Moigne, Ronan, Aftab, Blake T, Djakovic, Stevan, Dhimolea, Eugen, Valle, Eduardo, Murnane, Megan, King, Emily M, Soriano, Ferdie, Menon, Mary-Kamala, Wu, Zhi Yong, Wong, Stephen T, Lee, Grace J, Yao, Bing, Wiita, Arun P, Lam, Christine, Rice, Julie, Wang, Jinhai, Chesi, Marta, Bergsagel, P Leif, Kraus, Marianne, Driessen, Christoph, Kiss von Soly, Szerenke, Yakes, F Michael, Wustrow, David, Shawver, Laura, Zhou, Han-Jie, Martin, 3rd, Thomas G, Wolf, Jeffrey L, Mitsiades, Constantine S, Anderson, Daniel J, Rolfe, Mark

Volltext

Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma von Huang, Hector H., Ferguson, Ian D., Thornton, Alexis M., Bastola, Prabhakar, Lam, Christine, Lin, Yu-Hsiu T., Choudhry, Priya, Mariano, Margarette C., Marcoulis, Makeba D., Teo, Chin Fen, Malato, Julia, Phojanakong, Paul J., Martin, Thomas G., Wolf, Jeffrey L., Wong, Sandy W., Shah, Nina, Hann, Byron, Brooks, Angela N., Wiita, Arun P.

Volltext

Kidney Transplantation for Kidney Failure Due to Multiple Myeloma: Case Reports von Le, Thuy X., MD, Wolf, Jeffrey L., MD, Peralta, Carmen A., MD, Webber, Allison B., MD

Volltext

Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma von Sun, Haibo, Martin, Thomas G, Marra, John, Kong, Denice, Keats, Jonathon, Macé, Sandrine, Chiron, Marielle, Wolf, Jeffrey L, Venstrom, Jeffrey M, Rajalingam, Raja

Volltext

Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma von Fortuna, Gliceida Galarza, Banerjee, Rahul, Savid-Frontera, Constanza, Song, Jinming, Morán-Segura, Carlos M., Nguyen, Jonathan V., Lekakis, Lazaros, Fernandez-Pol, Sebastian, Samraj, Annie N., Naresh, Kikkeri N., Vazquez-Martinez, Mariola, Baz, Rachid C., Spiegel, Jay Y., Mikkilineni, Lekha, Gubatan, John M., Sidana, Surbhi, de Menezes Silva Corraes, Andre, Kalariya, Nilesh M., Patel, Krina K., Shim, Kevin G., Fonseca, Rafael, Ferreri, Christopher, Voorhees, Peter M., Richard, Shambavi, Valdes, Cesar Rodriguez, Sireesha Asoori, Wolf, Jeffrey L., Cowan, Andrew J., Sborov, Douglas W., Locke, Frederick L., Lin, Yi, Wang, Yinghong, Hansen, Doris K.

Volltext

Benzodiazepine and zolpidem prescriptions during autologous stem cell transplantation von Banerjee, Rahul, Lazar, Ann A., Dunn, Lisa, Knoche, Jennifer, Lo, Mimi, Arora, Shagun, Wong, Sandy W., Wolf, Jeffrey L., Martin, Thomas G., Dhruva, Anand, Shah, Nina

Volltext

Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells von Sherbenou, Daniel W, Aftab, Blake T, Su, Yang, Behrens, Christopher R, Wiita, Arun, Logan, Aaron C, Acosta-Alvear, Diego, Hann, Byron C, Walter, Peter, Shuman, Marc A, Wu, Xiaobo, Atkinson, John P, Wolf, Jeffrey L, Martin, Thomas G, Liu, Bin

Volltext

Review of the patient-centered communication landscape in multiple myeloma and other hematologic malignancies von LeBlanc, Thomas W., Baile, Walter F., Eggly, Susan, Bylund, Carma L., Kurtin, Sandra, Khurana, Monica, Najdi, Rani, Blaedel, Julie, Wolf, Jeffrey L., Fonseca, Rafael

Volltext

The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma von Vo, Josh N., Wu, Yi-Mi, Mishler, Jeanmarie, Hall, Sarah, Mannan, Rahul, Wang, Lisha, Ning, Yu, Zhou, Jin, Hopkins, Alexander C., Estill, James C., Chan, Wallace K. B., Yesil, Jennifer, Cao, Xuhong, Rao, Arvind, Tsodikov, Alexander, Talpaz, Moshe, Cole, Craig E., Ye, Jing C., Bergsagel, P. Leif, Auclair, Daniel, Cho, Hearn Jay, Robinson, Dan R., Chinnaiyan, Arul M.

Volltext

TAK‐228 (formerly MLN0128), an investigational oral dual TORC1/2 inhibitor: A phase I dose escalation study in patients with relapsed or refractory multiple myeloma, non‐Hodgkin ly... von Ghobrial, Irene M., Siegel, David S., Vij, Ravi, Berdeja, Jesus G., Richardson, Paul G., Neuwirth, Rachel, Patel, Chirag G., Zohren, Fabian, Wolf, Jeffrey L.

Volltext

DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma von Choudhry, Priya, Mariano, Margarette C., Geng, Huimin, Martin, Thomas G., Wolf, Jeffrey L., Wong, Sandy W., Shah, Nina, Wiita, Arun P.

Volltext

Antibody and T‐cell responses by ultra‐deep T‐cell receptor immunosequencing after COVID‐19 vaccination in patients with plasma cell dyscrasias von Chung, Alfred, Banbury, Barbara, Vignali, Marissa, Huang, Chiung‐Yu, Asoori, Sireesha, Johnson, Rachel, Kurtz, Theodore, Arora, Shagun, Wong, Sandy W., Shah, Nina, Martin, Thomas G., Wolf, Jeffrey L.

Volltext

Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipients von Keller, Jesse W, Andreadis, Charalambos, Damon, Lloyd E, Kaplan, Lawrence D, Martin, Thomas G, Wolf, Jeffrey L, Ai, Weiyun Z, Venstrom, Jeffrey M, Smith, Catherine C, Gaensler, Karin M.L, Hwang, Jimmy, Olin, Rebecca L

Volltext

Phase 1b trial of isatuximab, an anti‐CD38 monoclonal antibody, in combination with carfilzomib as treatment of relapsed/refractory multiple myeloma von Martin, Thomas G., Shah, Nina, Richter, Joshua, Vesole, David H., Wong, Sandy W., Huang, Chiung‐Yu, Madduri, Deepu, Jagannath, Sundar, Siegel, David S., Biran, Noa, Wolf, Jeffrey L., Parekh, Samir, Cho, Hearn J., Munster, Pamela, Richard, Shambavi, Ziti‐Ljajic, Samira, Chari, Ajai

Volltext

Outcomes of kidney transplant recipients with ESKD due to plasma cell dyscrasia: A case series von Dinh, Alex R., Wong, Sandy W., Martin, Thomas G., Wolf, Jeffrey L., Webber, Allison B.

Volltext

Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma von Panowski, Siler H, Kuo, Tracy C, Zhang, Yi, Chen, Amy, Geng, Tao, Aschenbrenner, Laura, Kamperschroer, Cris, Pascua, Edward, Chen, Wei, Delaria, Kathy, Farias, Santiago, Bateman, Marjorie, Dushin, Russell G, Chin, Sherman M, Van Blarcom, Thomas J, Yeung, Yik Andy, Lindquist, Kevin C, Chunyk, Allison G, Kuang, Bing, Han, Bora, Mirsky, Michael, Pardo, Ingrid, Buetow, Bernard, Martin, Thomas G, Wolf, Jeffrey L, Shelton, David, Rajpal, Arvind, Strop, Pavel, Chaparro-Riggers, Javier, Sasu, Barbra J

Volltext

The development of potential antibody-based therapies for myeloma von Sherbenou, Daniel W, Behrens, Christopher R, Su, Yang, Wolf, Jeffrey L, Martin, Thomas G, Liu, Bin

Volltext

Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in Myeloma von Banerjee, Rahul, Marsal, Jeffrey, Huang, Chiung-Yu, Lo, Mimi, Thiruvengadam, Swetha Kambhampati, Kennedy, Vanessa E., Arora, Shagun, Wolf, Jeffrey L., Martin, Thomas G., Wong, Sandy W., Shah, Nina

Volltext